Voss Capital, LP - 08 May 2025 SCHEDULE 13G Report for Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX)

Filing Manager
Voss Capital, LP
Reporting Manager
Voss Capital, LP
Security
Rein Therapeutics, Inc. Common Stock, $0.001 par value
Symbol
RNTX
Shares outstanding
22,818,857 shares
Disclosed Ownership
1,277,856 shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
14 May 2025, 20:26:02 UTC
Date of event
08 May 2025
Next filing
26 Sep 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Voss Value Master Fund, LP 2.5% 583,206 583,206 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner
Voss Value-Oriented Special Situations Fund, LP 1.4% 316,768 316,768 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner
Voss Advisors GP, LLC 3.9% 899,974 899,974 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Voss Capital, LP 5.6% 1,277,856 1,277,856 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Cocke Travis W. 5.6% 1,277,856 1,277,856 0 /s/ Travis W. Cocke Travis W. Cocke